170 related articles for article (PubMed ID: 21706320)
1. Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.
Jørgensen G; Lange B; Wanscher JH; Kjeldsen AD
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1765-70. PubMed ID: 21706320
[TBL] [Abstract][Full Text] [Related]
2. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
[TBL] [Abstract][Full Text] [Related]
3. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
[TBL] [Abstract][Full Text] [Related]
4. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Luk L; Mace JC; Bhandarkar ND; Sautter NB
Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
Lennox PA; Harries M; Lund VJ; Howard DJ
J Laryngol Otol; 1997 Jan; 111(1):34-7. PubMed ID: 9292128
[TBL] [Abstract][Full Text] [Related]
6. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
Hitchings AE; Lennox PA; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
[TBL] [Abstract][Full Text] [Related]
7. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.
Lennox PA; Hitchings AE; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):71-4. PubMed ID: 15794078
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
9. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
10. Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia.
Fiorella ML; Lillo L; Fiorella R
Acta Otorhinolaryngol Ital; 2012 Jun; 32(3):164-9. PubMed ID: 22767981
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of the Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT).
Peterson AM; Kallogjeri D; Spitznagel E; Chakinala MM; Schneider JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):999-1005. PubMed ID: 33022056
[TBL] [Abstract][Full Text] [Related]
12. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
Ghaheri BA; Fong KJ; Hwang PH
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
[TBL] [Abstract][Full Text] [Related]
13. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Harvey RJ; Kanagalingam J; Lund VJ
Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
[TBL] [Abstract][Full Text] [Related]
14. Hereditary hemorrhagic telangiectasia-laser treatment of epistaxis.
Poje G; Kavanagh MM
Ear Nose Throat J; 2017 Sep; 96(9):E10-E14. PubMed ID: 28931195
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
[TBL] [Abstract][Full Text] [Related]
16. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
[TBL] [Abstract][Full Text] [Related]
17. Use of a sprayed fibrin hemostatic sealant after laser therapy for hereditary hemorrhagic telangiectasia epistaxis.
Richmon JD; Tian Y; Husseman J; Davidson TM
Am J Rhinol; 2007; 21(2):187-91. PubMed ID: 17424877
[TBL] [Abstract][Full Text] [Related]
18. Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).
Wirsching KEC; Haubner F; Kühnel TS
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1891-1896. PubMed ID: 28070641
[TBL] [Abstract][Full Text] [Related]
19. Intranasal bevacizumab injections improve quality of life in HHT patients.
Steineger J; Geirdal AØ; Osnes T; Heimdal KR; Dheyauldeen S
Laryngoscope; 2020 May; 130(5):E284-E288. PubMed ID: 31287573
[TBL] [Abstract][Full Text] [Related]
20. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
